{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T16:01:00Z","timestamp":1779206460435,"version":"3.51.4"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[1996,3,1]],"date-time":"1996-03-01T00:00:00Z","timestamp":825638400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[1996,3]]},"DOI":"10.1007\/bf02245609","type":"journal-article","created":{"date-parts":[[2005,11,14]],"date-time":"2005-11-14T23:38:09Z","timestamp":1132011489000},"page":"95-106","source":"Crossref","is-referenced-by-count":54,"title":["5-HT modulation of auditory and visual sensorimotor gating: I. Effects of 5-HT releasers on sound and light prepulse inhibition in Wistar rats"],"prefix":"10.1007","volume":"124","author":[{"given":"J. H.","family":"Kehne","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. A.","family":"Padich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. C.","family":"McCloskey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. L.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. J.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02245609_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(91)90658-D","volume":"200","author":"S Benloucif","year":"1991","unstructured":"Benloucif S, Galloway MP (1991) Facilitation of dopamine release in vivo by serotonin agonists: studies with microdialysis. Eur J Pharmacol 200:1\u20138","journal-title":"Eur J Pharmacol"},{"key":"BF02245609_CR2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0014-2999(92)90023-W","volume":"215","author":"UV Berger","year":"1992","unstructured":"Berger UV, Gu XF, Azmitia EC (1992) The substituted amphetamines 3,4-methyledioxymethamphetamine, methamphetamine,p-chloroamphetamine, and fenfluramine induce 5-hydroxy-tryptamine release via a common mechanism blocked by fluoxetine and cocaine. Eur J Pharmacol 215:153\u2013160","journal-title":"Eur J Pharmacol"},{"key":"BF02245609_CR3","first-page":"124","volume-title":"Schizophrenia: scientific progress","author":"DL Braff","year":"1989","unstructured":"Braff DL, Geyer MA (1989) Sensorimotor gating and the neurobiology of schizophrenia: human and animal model studies. In: Schultz S, Tamminga C (eds) Schizophrenia: scientific progress. Oxford University Press, NY, pp 124\u2013136"},{"key":"BF02245609_CR4","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0920-9964(94)00043-8","volume":"14","author":"A Breier","year":"1995","unstructured":"Breier A (1995) Serotonin, schizophrenia and antipsychotic drug action. Schizophr Res 14:187\u2013202","journal-title":"Schizophr Res"},{"key":"BF02245609_CR5","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1176\/ajp.150.12.1862","volume":"150","author":"KS Cadenhead","year":"1993","unstructured":"Cadenhead KS, Geyer MA, Swerdlow NR (1993) Impaired startle prepulse inhibition and habituation in schizoptypal patients. Am J Psychiatry 150:1862\u20131867","journal-title":"Am J Psychiatry"},{"key":"BF02245609_CR6","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF02245519","volume":"111","author":"CW Callaway","year":"1993","unstructured":"Callaway CW, Wing LL, Nichols DE, Geyer MA (1993) Suppression of behavioral activity by norfenfluramine and related drugs in rats is not mediated by serotonin release. Psychopharmacology 111:169\u2013178","journal-title":"Psychopharmacology"},{"key":"BF02245609_CR7","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2190\/DCRP-U22M-AUMD-D84H","volume":"16","author":"RP Climko","year":"1989","unstructured":"Climko RP, Roehrich H, Sweeney DR, Al-Razi J (1989) Ecstasy: a review of MDMA and MDA. Int J Psychiatry Med 16:359\u2013372","journal-title":"Int J Psychiatry Med"},{"key":"BF02245609_CR8","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1021\/jo00301a004","volume":"55","author":"RJ Cregge","year":"1990","unstructured":"Cregge RJ, Wagner ER, Freedman J, Margolin AL (1990) Lipase-catalyzed transesterification in the synthesis of a new chiral unlabeled and carbon-14 labeled serotonin uptake inhibitor. J Org Chem 55:4237\u20134238","journal-title":"J Org Chem"},{"key":"BF02245609_CR9","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0091-3057(89)90455-3","volume":"33","author":"M Davis","year":"1989","unstructured":"Davis M, Commissaris RL, Yang S, Wagner KR, Kehne JH, Cassella JV, Boulis NM (1989) Spinal vs. supraspinal sites of action of the \u03b12-adrenergic agonists clonidine and ST-91 on the acoustic startle reflex. Pharmacol Biochem Behav 33:233\u2013240","journal-title":"Pharmacol Biochem Behav"},{"key":"BF02245609_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02245735","volume":"102","author":"M Davis","year":"1990","unstructured":"Davis M, Mansbach RS, Swerdlow NR, Campeau S, Braff DL, Geyer MA (1990) Apomorphine disrupts the inhibition of acoustic startle induced by weak prepulse in rats. Psychopharmacology 102:1\u20134","journal-title":"Psychopharmacology"},{"key":"BF02245609_CR11","first-page":"223","volume":"14","author":"JM Freedman","year":"1989","unstructured":"Freedman JM, Dudley M, Baron B, Ogden A, Holman T (1989) MDL 27,777: a selective inhibitor of serotonin uptake. Soc Neurosci Abstr 14:223","journal-title":"Soc Neurosci Abstr"},{"key":"BF02245609_CR12","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0014-2999(75)90145-4","volume":"33","author":"RW Fuller","year":"1975","unstructured":"Fuller RW, Perry KW, Molloy BB (1975) Reversible and irreversible phases of serotonin depletion by 4-chloroamphetamine. Eur J Pharmacol 33:119\u2013124","journal-title":"Eur J Pharmacol"},{"key":"BF02245609_CR13","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0361-9230(90)90241-Q","volume":"25","author":"MA Geyer","year":"1990","unstructured":"Geyer MA, Swerdlow NS, Mansbach RS, Braff DL (1990) Startle response models of sensorimotor gating and habituation deficits in schizophrenia. Brain Res Bull 25:485\u2013498","journal-title":"Brain Res Bull"},{"key":"BF02245609_CR14","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1080\/02791072.1986.10472364","volume":"18","author":"G Greer","year":"1986","unstructured":"Greer G, Tolpert R (1986) Subjective reports of the effects of MDMA in a clinical setting. J Psychoact Drugs 18:319\u2013327","journal-title":"J Psychoact Drugs"},{"key":"BF02245609_CR15","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/0006-3223(92)90183-Z","volume":"32","author":"C Grillon","year":"1992","unstructured":"Grillon C, Ameli R, Charney DS, Krystal J, Braff DL (1992) Startle gating deficits occur across prepulse intensities in schizophrenic patients. Biol Psychiatry 32:939\u2013943","journal-title":"Biol Psychiatry"},{"key":"BF02245609_CR16","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1037\/0033-295X.87.2.175","volume":"87","author":"HS Hoffman","year":"1980","unstructured":"Hoffman HS, Ison JR (1980) Reflex modification in the domain of startle: I. Some empirical findings and their implications for how the nervous system processes sensory input. Psychol Rev 87:175\u2013189","journal-title":"Psychol Rev"},{"key":"BF02245609_CR17","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1476-5381.1989.tb11887.x","volume":"96","author":"PH Hutson","year":"1989","unstructured":"Hutson PH, Curzon G (1989) Concurrent determination of effects ofp-chloroamphetamine on central extracellular 5-hydroxy-tryptamine concentration and behavior. Br J Pharmacol 96:801\u2013806","journal-title":"Br J Pharmacol"},{"key":"BF02245609_CR18","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0014-2999(89)90464-0","volume":"164","author":"R Invernizzi","year":"1989","unstructured":"Invernizzi R, Bertorelli R, Consolo S, Garattini S, Samanin R (1989) Effects of thel isomer of fenfluramine on dopamine mechanisms in rat brain: further studies. Eur J Pharmacol 164:241\u2013248","journal-title":"Eur J Pharmacol"},{"key":"BF02245609_CR19","first-page":"488","volume":"4","author":"LL Judd","year":"1992","unstructured":"Judd LL, McAdams L, Budnick B, Braff DL (1992) Sensory gating deficits in schizophrenia: new result. Am J Psychiatry 4:488\u2013493","journal-title":"Am J Psychiatry"},{"key":"BF02245609_CR20","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/0920-9964(93)90296-U","volume":"9","author":"LP Karper","year":"1993","unstructured":"Karper LP, Freeman GK, Morgan CA, Grillon C, Charney DS, Krystal JH (1993) Prepulse inhibition of the acoustic startle response and measure of attention in schizophrenic subjects. Schizophr Res 9:160","journal-title":"Schizophr Res"},{"key":"BF02245609_CR21","first-page":"78","volume":"260","author":"JH Kehne","year":"1992","unstructured":"Kehne JH, McCloskey TC, Taylor VL, Black CK, Fadayel GM, Schmidt CJ (1992) Effects of the serotonin releasers 3,4-methylenedioxymethamphetamine (MDMA), 4-chloroamphetamine (PCA) and fenfluramine on acoustic and tactile startle reflexes in rats. J Pharmacol Exp Ther 260:78\u201389","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02245609_CR22","first-page":"1775","volume":"20","author":"JH Kehne","year":"1994","unstructured":"Kehne JH, McCloskey TC, Padich RA, Taylor VL, Schmidt CJ (1994) Serotonergic overactivation, like dopaminergic overactivation or glutamate underactivation, disrupts cross-modal sensory gating as measured by auditory and visual prepulse inhibition in rats. Soc Neurosci Abstr 20:1775","journal-title":"Soc Neurosci Abstr"},{"key":"BF02245609_CR23","unstructured":"Kehne JH, Baron BM, Carr AA, Chaney SF, Elands J, Feldman DJ, Frank RA, van Giersbergen PLM, McCloskey TC, Johnson MP, McCarty DR, Poirot M, Senyah Y, Siegel BW, Widmaier C (1996a) Preclinical characterization of the potential of the putative atypical antipsychotic MDL 100,907 as a potent 5-HT2A antagonist with a favorable CNS safety profile. J Pharmacol Exp Ther (in press)"},{"key":"BF02245609_CR24","doi-asserted-by":"crossref","unstructured":"Kehne JH, Ketteler HJ, McCloskey TC, Sullivan CK, Dudley MW, Schmidt CJ (1996b) Effects of the selective 5-HT2A receptor antagonist MDL 100,907 on MDMA-induced locomotor stimulation in rats. Neuropsychopharmacol (in press)","DOI":"10.1016\/0893-133X(95)00160-F"},{"key":"BF02245609_CR25","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0006-3223(91)90025-H","volume":"30","author":"VA Keith","year":"1991","unstructured":"Keith VA, Mansbach RS, Geyer MA (1991) Failure of haloperidol to block the effects of phencyclidine and dizocilpine on prepulse inhibition of startle. Biol Psychiatry 30:557\u2013566","journal-title":"Biol Psychiatry"},{"key":"BF02245609_CR26","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3109\/00952999209026070","volume":"18","author":"JH Krystal","year":"1992","unstructured":"Krystal JH, Price LH, Opsahl C, Ricaurte GA, Heninger GR (1992) Chronic 3,4-methylenedioxymethamphetamine (MDMA) use: effects on mood and neuropsychological function? Am J Drug Alcohol Abuse 18:331\u2013341","journal-title":"Am J Drug Alcohol Abuse"},{"key":"BF02245609_CR27","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0014-2999(91)90253-M","volume":"202","author":"RS Mansbach","year":"1991","unstructured":"Mansbach RS (1991) Effects of NMDA receptor ligands on sensorimotor gating in the rat. Eur J Pharmacol 202:61\u201366","journal-title":"Eur J Pharmacol"},{"key":"BF02245609_CR28","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/BF00212846","volume":"94","author":"RS Mansbach","year":"1988","unstructured":"Mansbach RS, Geyer MA, Braff DL (1988) Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology 94:507\u2013514","journal-title":"Psychopharmacology"},{"key":"BF02245609_CR29","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0014-2999(89)90746-2","volume":"167","author":"RS Mansbach","year":"1989","unstructured":"Mansbach RS, Braff DL, Geyer MA (1989) Prepulse inhibition of the acoustic startle response is disrupted byN-ethyl-3,4-methylenedioxymethamphetamine (MDEA) in the rat. Eur J Pharmacol 167:49\u201355","journal-title":"Eur J Pharmacol"},{"key":"BF02245609_CR30","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/00004714-198904000-00007","volume":"9","author":"BD Marshall Jr","year":"1989","unstructured":"Marshall BD Jr, Glynn SM, Midha KK, Hubbard JW, Bowen LL, Banzett L, Mintz J, Liberman RP (1989) Adverse effects of fenfluramine in treatment refractory schizophrenia. J Clin Psychopharmacol 9:110\u2013115","journal-title":"J Clin Psychopharmacol"},{"key":"BF02245609_CR31","first-page":"587","volume":"43","author":"H Meltzer","year":"1991","unstructured":"Meltzer H (1991) Effects of antipsychotic drugs on serotonin receptors. Pharmacol Rev 43:587\u2013604","journal-title":"Pharmacol Rev"},{"key":"BF02245609_CR32","first-page":"238","volume":"251","author":"H Meltzer","year":"1989","unstructured":"Meltzer H, Matzubara S, Lee J (1989) Classification of typical and atypical antipsychotic drugs on the basis of dopamine D1, D2 and serotonin2 pKi values. J Pharmacol Exp Ther 251:238\u2013246","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02245609_CR33","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/npp.1994.6","volume":"10","author":"R Mongeau","year":"1994","unstructured":"Mongeau R, de Montgny C, Blier P (1994) Electrophysiological evidence for desensitization of a2-adrenoreceptors on serotonin terminals following long-term treatment with drugs increasing norepinephrine synaptic concentrations. Neuropsychopharmacology 10:41\u201351","journal-title":"Neuropsychopharmacology"},{"key":"BF02245609_CR34","first-page":"163","volume":"13","author":"PC Moser","year":"1996","unstructured":"Moser PC, Moran PM, Frank RA, Kehne JH (1996) Reversal of amphetamine-induced behaviours by MDL 100,907, selective 5-HT2A antagonist. Behav Brain Res 13:163\u2013167","journal-title":"Behav Brain Res"},{"key":"BF02245609_CR35","volume-title":"Role of serotonin in an animal model of defective sensorimotor gating in schizophrenia","author":"RA Padich","year":"1993","unstructured":"Padich RA (1993) Role of serotonin in an animal model of defective sensorimotor gating in schizophrenia. Doctoral Dissertation, Department of Psychology, University of Cincinnati, Cincinnati, Ohio"},{"key":"BF02245609_CR36","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF02245610","volume":"124","author":"RA Padich","year":"1996","unstructured":"Padich RA, McCloskey TC, Kehne JH (1996) 5-HT modulation of auditory and visual sensorimotor gating: II. Effects of the 5-HT2A antagonist MDL 100,907 on disruption of sound and light prepulse inhibition produced by 5-HT agonists in Wistar rats. Psychopharmacology 124:107\u2013116","journal-title":"Psychopharmacology"},{"key":"BF02245609_CR37","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1007\/BF02245008","volume":"112","author":"MG Palfreyman","year":"1993","unstructured":"Palfreyman MG, Schmidt CJ, Sorensen SM, Dudley MW, Kehne JH, Moser P, Gittos MW, Carr AA (1993) Electrophysiological, biochemical, and behavioral evidence for 5-HT2 and 5-HT3 mediated control of dopaminergic function. In: Kahn RS (ed) Proceedings of American College of Neurophysiology Symposium. Psychopharmacology 112:S60-S67","journal-title":"Psychopharmacology"},{"key":"BF02245609_CR38","first-page":"273","volume":"1","author":"SJ Peroutka","year":"1988","unstructured":"Peroutka SJ, Newman H, Harris H (1988) Subjective effects of 3,4-methylenedioxymethamphetamine in recreational users. Neuropsychopharmacology 1:273\u2013277","journal-title":"Neuropsychopharmacology"},{"key":"BF02245609_CR39","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2165\/00003495-197510040-00001","volume":"10","author":"RM Pinder","year":"1975","unstructured":"Pinder RM, Brogden RN, Sawyer PR, Speight TM, Avery GS (1975) Fenfluramine: a review of its pharmacological properties and therapeutic efficacy in obesity. Drugs 10:241\u2013323","journal-title":"Drugs"},{"key":"BF02245609_CR40","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ddr.430230110","volume":"23","author":"GC Rigdon","year":"1991","unstructured":"Rigdon GC, Viik K (1991) Prepulse inhibition as a screening test for potential antipsychotics. Drug Dev Res 23:91\u201399","journal-title":"Drug Dev Res"},{"key":"BF02245609_CR41","first-page":"486","volume":"263","author":"GC Rigdon","year":"1992","unstructured":"Rigdon GC, Weatherspoon JK (1992) 5-Hydroxytryptamine1a receptor agonists block prepulse inhibition of acoustic startle reflex. J Pharmacol Exp Ther 263:486\u2013493","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02245609_CR42","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1749-6632.1978.tb31525.x","volume":"305","author":"E Sanders-Bush","year":"1978","unstructured":"Sanders-Bush E, Sterank LR (1978) Immediate and long-term effects ofp-chloroamphetamine on brain amines. In: Jakoby JH, Lytle LD (eds) Serotonergic neurotoxins. Ann NY Acad Sci 305:208\u2013221","journal-title":"Ann NY Acad Sci"},{"key":"BF02245609_CR43","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0091-3057(88)90390-5","volume":"31","author":"MD Schecter","year":"1988","unstructured":"Schecter MD (1988) Serotonergic-dopaminergic mediation of 3,4-methylenedioxymethamphetamine (MDMA, \u201cecstasy\u201d). Pharmacol Biochem Behav 31:817\u2013824","journal-title":"Pharmacol Biochem Behav"},{"key":"BF02245609_CR44","first-page":"1","volume":"240","author":"CJ Schmidt","year":"1987","unstructured":"Schmidt CJ (1987) Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. J Pharmacol Exp Ther 240:1\u20137","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02245609_CR45","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1749-6632.1990.tb16917.x","volume":"600","author":"CJ Schmidt","year":"1990","unstructured":"Schmidt CJ, Kehne JH (1990) Neurotoxicity of MDMA: neurochemical effects. In: The neuropharmacology of serotonin. Ann NY Acad Sci 600:665\u2013681","journal-title":"Ann NY Acad Sci"},{"key":"BF02245609_CR46","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0014-2999(90)90254-4","volume":"181","author":"CJ Schmidt","year":"1990","unstructured":"Schmidt CJ, Taylor VL (1990) Reversal of the acute effects of 3,4-methylenedioxymethamphetamine by 5-HT uptake inhibitors. Eur J Pharmacol 181:133\u2013136","journal-title":"Eur J Pharmacol"},{"key":"BF02245609_CR47","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0014-2999(92)90743-N","volume":"220","author":"CJ Schmidt","year":"1992","unstructured":"Schmidt CJ, Black CK, Taylor VL, Fadayel GM, Humphreys TM, Nieduzak TR, Sorensen SM (1992) The 5-HT2 receptor antagonist, MDL 28,133A, disrupts the serotonergic-dopaminergic interaction mediating the neurochemical effects of 3,4-methylenedioxymethamphetamine. Eur J Pharmacol 220:151\u2013159","journal-title":"Eur J Pharmacol"},{"issue":"Suppl 2","key":"BF02245609_CR48","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00004850-199311002-00004","volume":"8","author":"CJ Schmidt","year":"1993","unstructured":"Schmidt CJ, Kehne JH, Carr AA, Fadayel GM, Humphreys TM, Ketteler HJ, McCloskey TC, Padich RA, Taylor VL, Sorensen SM (1993) Contribution of serotonin neurotoxins to understanding psychiatric disorders: the role of 5-HT2 receptors in schizophrenia and antipsychotic activity. Int Clin Psychopharmacol 8 [Suppl 2]:25\u201332","journal-title":"Int Clin Psychopharmacol"},{"key":"BF02245609_CR49","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1016\/0024-3205(95)00210-W","volume":"56","author":"CJ Schmidt","year":"1995","unstructured":"Schmidt CJ, Sorensen SM, Kehne JH, Carr AA, Palfreyman MG (1995) The role of 5-HT2A receptors in antipsychotic activity. Life Sci 56:2209\u20132222","journal-title":"Life Sci"},{"key":"BF02245609_CR50","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0006-8993(89)91189-X","volume":"482","author":"D Schwartz","year":"1989","unstructured":"Schwartz D, Hernandez L, Hoebel BG (1989) Fenfluramine administered systemically or locally increases extracellular serotonin in the lateral hypothalamus as measured by microdialysis. Brain Res 482:261\u2013270","journal-title":"Brain Res"},{"key":"BF02245609_CR51","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/0031-9384(89)90040-1","volume":"46","author":"H Shimizu","year":"1989","unstructured":"Shimizu H, Bray GA (1989) Hypothalamic monoamines measured by microdialysis in rats treated with 2-deoxy-glucose ord-fenfluramine. Physiol Behav 46:799\u2013807","journal-title":"Physiol Behav"},{"key":"BF02245609_CR52","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0028-3908(94)90074-4","volume":"33","author":"TA Sipes","year":"1994","unstructured":"Sipes TA, Geyer MA (1994) Multiple serotonin receptor subtypes modulate prepulse inhibition of the startle response in rats. Neuropharmacology 33:441\u2013448","journal-title":"Neuropharmacology"},{"key":"BF02245609_CR53","first-page":"684","volume":"266","author":"SM Sorensen","year":"1993","unstructured":"Sorensen SM, Kehne JH, Fadayel GM, Humphreys TM, Ketteler HJ, Sullivan CK, Taylor VL, Schmidt CJ (1993) Characterization of the 5-HT2 receptor antagonist MDL 100,907 as a putative antipsychotic: behavioral, electrophysiological and neurochemical studies. J Pharmacol Exp Ther 266:684\u2013691","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02245609_CR54","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/BF02244616","volume":"100","author":"NR Swerdlow","year":"1990","unstructured":"Swerdlow NR, Mansbach RS, Geyer MA, Pulvirenti L, Braff DL (1990) Amphetamine disruption of prepulse inhibition of acoustic startle is reversed by depletion of mesolimbic dopamine. Psychopharmacology 100:413\u2013416","journal-title":"Psychopharmacology"},{"key":"BF02245609_CR55","first-page":"530","volume":"256","author":"NR Swerdlow","year":"1991","unstructured":"Swerdlow NR, Keith VA, Braff DL, Geyer MA (1991) Effects of spiperone, SCH 23390, and clozapine on apomorphine inhibition of sensorimotor gating of the startle reflex in the rat. J Pharmacol Exp Ther 256:530\u2013536","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02245609_CR56","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/0006-3223(93)90300-3","volume":"33","author":"NR Swerdlow","year":"1993","unstructured":"Swerdlow NR, Benbow CH, Zisook S, Geyer MA, Braff DL (1993) A preliminary assessment of sensorimotor gating in patients with obsessive compulsive disorder. Biol Psychiatry 33:298\u2013301","journal-title":"Biol Psychiatry"},{"key":"BF02245609_CR57","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1136\/jnnp.58.2.192","volume":"58","author":"NR Swerdlow","year":"1995","unstructured":"Swerdlow NR, Paulsen J, Braff DL, Butters N, Geyer MA, Swenson MR (1995) Impaired prepulse inhibition of acoustic and tactile startle response in patients with Huntington's disease. J Neurol Neurosurg Psychiatry 58:192\u2013200","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BF02245609_CR58","first-page":"25","volume":"349","author":"A-U Trendlenburg","year":"1994","unstructured":"Trendlenburg A-U, Tredlenburg M, Starke K, Limburger N (1994) Release-inhibiting \u03b12-adrenoceptors at serotonergic axons in rat and rabbit brain cortex: evidence for pharmacological identity with \u03b12-autoreceptors. Naunyn-Schmiedeberg's Arch Pharmacol 349:25\u201333","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"BF02245609_CR59","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0014-2999(88)90564-X","volume":"148","author":"BK Yamamoto","year":"1988","unstructured":"Yamamoto BK, Spanos LJ (1988) The acute effects of methylenedioxymethamphetamine on dopamine release in the awakebehaving rats. Eur J Pharmacol 148:195\u2013203","journal-title":"Eur J Pharmacol"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02245609.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02245609\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02245609","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T17:33:26Z","timestamp":1557941606000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02245609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,3]]},"references-count":59,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[1996,3]]}},"alternative-id":["BF02245609"],"URL":"https:\/\/doi.org\/10.1007\/bf02245609","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,3]]}}}